Revive Therapeutics Ltd (RVVTF)

[tripmcneely]

Yes and the PR is a written response to the public regarding said written responses from the GDA where RVVTF said no thanks we will ignore and continue with previous end points which were already rejected by the FDA.

Hospitalizations and deaths are no longer a thing to 99%+ of the public with these weaker strains. Hence why FDA wants time to resolved symptoms.

Does this drug help people who get sick with covid get better faster yes or no? That’s it. Thats what the FDA wants to know. Not whether they will die.

The FDA is looking for essentially a stronger Dayquil for covid. Plain and simple.

Revive is ignoring that request apparently. Or the data doesn’t support it. That simple